Advanced search
Showing results 961 to 980 on 8263 in total
-
Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.
Tristan Ferry, Agathe Sénéchal, Marie-Claude Gagnieu, André Boibieux, Frédéric Laurent, Thomas Perpoint, Michel Tod, Christian Chidiac
-
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure
Anne-Charlotte Castellan, M. Tod, François Gueyffier, M. Audars, F. Cambriels, Berouz Kassai, Patrice Nony
-
In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
Sylvain Goutelle, Laurent Bourguignon, Nathalie Bleyzac, J. Berry, F. Clavel-Grabit, M. Tod
-
Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach
M. Tod, C. Nkoud-Mongo, François Gueyffier
-
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.
Floriane Lignet, Sébastien Benzekry, Shelby Wilson, Frédérique Billy, Olivier Saut, Michel Tod, Benoit You, A. Adda Berkane, S. Kassour, M. X. Wei, Emmanuel Grenier, Benjamin Ribba
-
How to solve the problem of spontaneous bacterial clearance when testing new antibiotic treatment: results on experimental pneumonia due to a derepressed cephalosporinase-producing Enterobacter cloacae
Anne Jacolot, Claire Judel, Kamel Louchahi, Michel Tod, Sandrine Marchand, Olivier Petitjean, Olivier Mimoz
-
Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus
Florent Valour, Judith Karsenty, Anissa Bouaziz, Florence Ader, Michel Tod, Sebastien Lustig, Frédéric Larent, René Ecochard, Christian Chidiac, Tristan Ferry
-
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial
Olivier Lortholary, Caroline Roussillon, Céline Boucherie, Christophe Padoin, Marie-Laure Chaix, Guillaume Breton, Agathe Rami, Nicolas Veziris, Olivier Patey, Eric Caumes, Thierry May, Jean-Michel Molina, Jérôme Robert, Michel Tod, Catherine Fagard, Geneviève Chêne
-
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases
Charry F. De, O. Colomban, Benoit You, A. Ruffion, P. Paparel, M. Wilbaux, M. Tod, G. Freyer, P. Perrin
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année : propositions pour modifier le contenu de l’enseignement
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, Benoit Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, B. Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Conduite à tenir en cas d’association d’un alpha-bloquant et d’un inhibiteur puissant du cytochrome 3A4
N. Bensalah, S. Garcia, F.X. Rose, P. Bedouch, O. Conort, M. Juste, R. Roubille, Benoit Allenet, M. Tod, B. Charpiat
-
Respiratory depression related to multiple drug–drug interactions precipitated by a fluconazole loading dose in a patient treated with oxycodone
Bruno Charpiat, Michel Tod, Benjamin Darnis, Guillaume Boulay, Marie-Claude Gagnieu, Jean‐yves Mabrut
-
Classifying pharmacists' interventions recorded in observational databases: Are they all necessary and appropriate?
Bruno Charpiat, Pierrick Bedouch, Michel Tod, Benoit Allenet
-
Thesaurus for off-label indications for systemic antifungal agents
A.L. Bienvenu, M. Aussedat, F. Maldonado, R. Kavafian, C. Barbieri, M. Tod, C. Paillet, L. Juillard, C. Chidiac, G. Leboucher
-
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies
Pauline Corbaux, Mévidette El-Madani, Michel Tod, Julien Péron, Denis Maillet, Jonathan Lopez, Gilles Freyer, Benoit You
-
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria
Yobouet Ines Kouakou, Michel Tod, Gilles Leboucher, Adeline Lavoignat, Guillaume Bonnot, Anne-Lise Bienvenu, Stephane Picot
-
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments
Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, Elisabeth Polard, Béatrice Saint-Salvi, Agnés Sommet, Michel Tod, Chantal Barin-Le-Guellec
-
Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)
Patrick Robelin, Michel Tod, Olivier Colomban, Joel Lachuer, Isabelle Ray-Coquard, Gaëtan De Rauglaudre, Florence Joly, Annick Chevalier-Place, Pierre Combe, Alain Lortholary, Salima Hamizi, Nadia Raban, Gwénaël Ferron, Jérôme Meunier, Dominique Berton-Rigaud, Jérôme Alexandre, Marie-Christine Kaminsky, Coraline Dubot, Alexandra Leary, Emmanuelle Malaurie, Benoit You
-
Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients
A. L. Bienvenu, P. Pradat, A. Plesa, V. Leclerc, V. Piriou, J. L. Fellahi, L. Argaud, T. Rimmele, J. Menotti, F. Aubrun, J. C. Richard, M. C. Gagnieu, F. Parant, C. Chidiac, G. Leboucher, M. Tod, S. Goutelle